home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Medpace Holdings, Inc. - Common Stock (NQ:MEDP)

561.65 -7.20 (-1.27%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Medpace Holdings, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

3 Top Growth Stocks to Carry You Through 2023 ↗

November 16, 2023

Interest rate headwinds have abated, providing a catalyst for these growth stocks to buy to rally into year-end.

Via InvestorPlace

9 Health Care Stocks With Whale Alerts In Today's Session ↗

November 16, 2023

Via Benzinga

Stock Buybacks: The Good and the Bad ↗

November 11, 2023

We've also got a look at takeaways from a trip to Las Vegas and some financial horror stories.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

November 08, 2023

Via Benzinga

Top-Notch Medpace Smashes Forecasts And Rockets 19% Toward A Record ↗

October 24, 2023

The company netted more than $600 million in new business awards, up 30%.

Via Investor's Business Daily

Medpace Hldgs's Earnings: A Preview ↗

October 20, 2023

Via Benzinga

Unlocking the Growth Potential of NASDAQ:MEDP. ↗

October 18, 2023

Unlocking the Growth Potential of MEDPACE HOLDINGS INC (NASDAQ:MEDP).

Via Chartmill

Delving into NASDAQ:MEDP's Growth Prospects. ↗

September 27, 2023

Why the CANSLIM investor may take a look at MEDPACE HOLDINGS INC (NASDAQ:MEDP).

Via Chartmill

Why Asbury Automotive Group Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

October 24, 2023

Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares climbed 169% to $1.56 after the company announced it selected a lead Alzheimer's drug candidate following proof-of-concept study data.

Via Benzinga

General Electric, Verizon, Cleveland-Cliffs And Other Big Stocks Moving Higher On Tuesday ↗

October 24, 2023

U.S. stocks traded higher Tuesday, with the Nasdaq Composite gaining over 100 points. Here are some big stocks recording gains in the trading session. ImmunityBio, Inc. (NASDAQ: IBRX) shares rose...

Via Benzinga

Topics Stocks

Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023 ↗

October 24, 2023

Via Benzinga

Matson To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

October 24, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page

Via Benzinga

Is NASDAQ:MEDP suited for growth investing? ↗

September 05, 2023

Is MEDPACE HOLDINGS INC (NASDAQ:MEDP) suited for growth investing?

Via Chartmill

Exploring NASDAQ:MEDP's growth characteristics. ↗

August 14, 2023

MEDPACE HOLDINGS INC (NASDAQ:MEDP) may be suited for growth investing, we'll explore why in this article.

Via Chartmill

Checking In on Medpace, Autoliv, and 401(k) Plans ↗

August 05, 2023

This podcast helps make the world smarter, happier, and richer.

Via The Motley Fool

A Preview Of Medpace Hldgs's Earnings ↗

July 21, 2023

Via Benzinga

Why Medpace Holdings Stock Is Rising After-Hours ↗

October 23, 2023

Medpace Holdings Inc (NASDAQ: MEDP) shares are trading higher in Monday's after-hours session after the company released its third-quarter results.

Via Benzinga

Medpace Holdings, Inc. Reports Third Quarter 2023 Results

October 23, 2023

From Medpace Holdings, Inc.

Via Business Wire

Earnings Scheduled For October 23, 2023 ↗

October 23, 2023

Companies Reporting Before The Bell • Koninklijke Philips (NYSE:PHG) is projected to report quarterly earnings at $0.33 per share on revenue of $4.65 billion.

Via Benzinga

3 Best Stocks to Buy With $300 Right Now ↗

September 28, 2023

Whether driven by unstoppable megatrends or wide moats, these three stocks are poised to continue growing.

Via The Motley Fool

Medpace Holdings, Inc. to Report Third Quarter 2023 Financial Results on October 23, 2023

September 26, 2023

From Medpace Holdings, Inc.

Via Business Wire

Stock Market Rallies Amid Huge Earnings, Fed Rate Hike, Inflation Data: Weekly Review ↗

July 28, 2023

Despite Thursday's downside reversal, the major indexes had a solid advance.

Via Investor's Business Daily

Medpace Outperforms Q2 Expectations: Analyst Says High Expectations, Softer Margins Will Likely Temper Enthusiasm ↗

July 25, 2023

Medpace Holdings Inc (NASDAQ: MEDP) reported Q2 revenue of $460.9 million, up 31.2%Y/Y, beating the consensus of $433.69 million, representing a backlog

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 24, 2023

Via Benzinga

Medpace Holdings, Inc. Reports Second Quarter 2023 Results

July 24, 2023

From Medpace Holdings, Inc.

Via Business Wire

4 Top Stocks to Buy in July and Hold Forever ↗

July 10, 2023

The long-term growth stories of these businesses are still in their early chapters -- now may be the perfect time to buy.

Via The Motley Fool

Medpace Holdings, Inc. to Report Second Quarter 2023 Financial Results on July 24, 2023

July 05, 2023

From Medpace Holdings, Inc.

Via Business Wire

Boeing, CyberArk Lead 5 Stocks Near Buy Points ↗

June 17, 2023

The market rally is going strong, but watch out for a potential pullback.

Via Investor's Business Daily

Healthcare Technology: 3 Companies to Keep an Eye On Now ↗

June 15, 2023

Healthcare technology stocks have generated high returns in the past and are likely to do so going forward as well.

Via InvestorPlace

10 Health Care Stocks With Whale Alerts In Today's Session ↗

June 09, 2023

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com